These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8182701)
1. Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studies. Fiorini I; Nacci V; Ciani SM; Garofalo A; Campiani G; Savini L; Novellino E; Greco G; Bernasconi P; Mennini T J Med Chem; 1994 May; 37(10):1427-38. PubMed ID: 8182701 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers. Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127 [TBL] [Abstract][Full Text] [Related]
3. A concerted study using binding measurements, X-ray structural data, and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines toward mitochondrial benzodiazepine receptors. Dalpiaz A; Bertolasi V; Borea PA; Nacci V; Fiorini I; Campiani G; Mennini T; Manzoni C; Novellino E; Greco G J Med Chem; 1995 Nov; 38(23):4730-8. PubMed ID: 7473601 [TBL] [Abstract][Full Text] [Related]
4. A comparative molecular field analysis model for 6-arylpyrrolo[2,1-d] [1,5]benzothiazepines binding selectively to the mitochondrial benzodiazepine receptor. Greco G; Novellino E; Fiorini I; Nacci V; Campiani G; Ciani SM; Garofalo A; Bernasconi P; Mennini T J Med Chem; 1994 Nov; 37(24):4100-8. PubMed ID: 7990110 [TBL] [Abstract][Full Text] [Related]
5. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]
6. Research on compounds with psychotropic activity. IX--Synthesis of 6-p-methoxyphenylpyrrolo[2,1-d][1,5]benzothiazepines and evaluation of their affinities for BDZ and GABA receptor subtypes. Nacci V; Fiorini I; Garofalo A; Cagnotto A Farmaco; 1990 May; 45(5):545-58. PubMed ID: 2171544 [TBL] [Abstract][Full Text] [Related]
8. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure. Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351 [TBL] [Abstract][Full Text] [Related]
9. [Compounds with psychotropic activity. VIII. Synthesis and sedative activity of various 9-substituted derivatives of 5-phenylpyrrolo[2,1-d][1,5] benzothiazepine and cis-4,5-dihydro-4-hydroxy-5-phenylpyrrolo[2,1-d][1,5]benzothiazepine]. Nacci V; Fiorini I; Vomero S; Taddei I; Taddei E Farmaco Sci; 1984 Apr; 39(4):289-304. PubMed ID: 6723946 [TBL] [Abstract][Full Text] [Related]
10. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VIII-Synthesis and inhibition of benzodiazepine receptor binding of some derivatives of triazino[3,4-c]-1,4-benzothiazine and triazino[3,4-d]-1,5-benzothiazepine, two new heterocyclic ring systems. Perioli L; Ambrogi V; Grandolini G; Giusti L; Lucacchini A; Martini C Farmaco; 1994 Apr; 49(4):245-51. PubMed ID: 8049004 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel class of pyrrolo-[1,2,5]benzothiadiazepine derivatives as potential anti-schistosomal agents. Chen J; Sun W; Yang J; Sun H; Wang Z; Dong L; Qiao C; Xia CM Bioorg Med Chem Lett; 2013 Jul; 23(13):3785-7. PubMed ID: 23707253 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands. Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Ciani SM; Greco G; Novellino E; Williams DC; Zisterer DM; Woods MJ; Mihai C; Manzoni C; Mennini T J Med Chem; 1996 Aug; 39(18):3435-50. PubMed ID: 8784441 [TBL] [Abstract][Full Text] [Related]
13. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VII. Synthesis and inhibition of benzodiazepine receptor binding of some 4,5-dihydro-tetrazolo[5,1-d]-1,5-benzothiazepines and 5-phenyl-s-triazolo[3,4-d]-1,5-benzothiazepines. Ambrogi V; Grandolini G; Perioli L; Giusti L; Lucacchini A; Martini C Farmaco; 1993 May; 48(5):665-76. PubMed ID: 8393678 [TBL] [Abstract][Full Text] [Related]
14. [3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization. Zobrist RH; Mecca TE J Pharmacol Exp Ther; 1990 May; 253(2):461-5. PubMed ID: 2338642 [TBL] [Abstract][Full Text] [Related]
15. Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling. Anzini M; Cappelli A; Vomero S; Seeber M; Menziani MC; Langer T; Hagen B; Manzoni C; Bourguignon JJ J Med Chem; 2001 Apr; 44(8):1134-50. PubMed ID: 11312914 [TBL] [Abstract][Full Text] [Related]
16. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. XI. Synthesis and biological activity of several naphtho- and quinolino-1,4-thiazine and -1,4-thiazepine derivatives containing the imidazole ring. Grandolini G; Ambrogi V; Perioli L; D'Eramo D; Bernardini C; Giampietri A Farmaco; 1997; 52(6-7):379-84. PubMed ID: 9372589 [TBL] [Abstract][Full Text] [Related]
17. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors. Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands. Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833 [TBL] [Abstract][Full Text] [Related]
19. Sugar-based enantiomeric and conformationally constrained pyrrolo[2,1-c][1,4]-benzodiazepines as potential GABAA ligands. Araújo AC; Rauter AP; Nicotra F; Airoldi C; Costa B; Cipolla L J Med Chem; 2011 Mar; 54(5):1266-75. PubMed ID: 21314193 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. Atwal KS; Bergey JL; Hedberg A; Moreland S J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]